Reverse engineering the ultrasound contrast agent
- PMID: 30396507
- PMCID: PMC6268001
- DOI: 10.1016/j.cis.2018.10.004
Reverse engineering the ultrasound contrast agent
Abstract
In this review, a brief history and current state-of-the-art is given to stimulate the rational design of new microbubbles through the reverse engineering of current ultrasound contrast agents (UCAs). It is shown that an effective microbubble should be biocompatible, echogenic and stable. Physical mechanisms and engineering calculations have been provided to illustrate these properties and how they can be achieved. The reverse-engineering design paradigm is applied to study current FDA-approved and commercially available UCAs. Given the sophistication of microbubble designs reported in the literature, rapid development and adoption of ultrasound device hardware and techniques, and the growing number of revolutionary biomedical applications moving toward the clinic, the field of Microbubble Engineering is fertile for breakthroughs in next-generation UCA technology. It is up to current and future microbubble engineers and clinicians to push forward with regulatory approval and clinical adoption of advanced UCA technologies in the years to come.
Keywords: Coalescence; Dissolution; Drug delivery; Imaging; Microbubble; Surface forces.
Copyright © 2018 Elsevier B.V. All rights reserved.
Figures







Similar articles
-
Formulation and Characterization of Chemically Cross-linked Microbubble Clusters.Langmuir. 2019 Aug 20;35(33):10977-10986. doi: 10.1021/acs.langmuir.9b00475. Epub 2019 Aug 7. Langmuir. 2019. PMID: 31310715 Free PMC article.
-
Diagnostic and therapeutic research on ultrasound microbubble/nanobubble contrast agents (Review).Mol Med Rep. 2015 Sep;12(3):4022-4028. doi: 10.3892/mmr.2015.3941. Epub 2015 Jun 16. Mol Med Rep. 2015. PMID: 26081968 Review.
-
Commercially Available Ultrasound Contrast Agents: Factors Contributing to Favorable Outcomes With Ultrasound-Mediated Drug Delivery and Ultrasound Localization Microscopy Imaging.Invest Radiol. 2025 Apr 22. doi: 10.1097/RLI.0000000000001197. Online ahead of print. Invest Radiol. 2025. PMID: 40262129
-
Ultrasound contrast agents: microbubbles made simple for the pediatric radiologist.Pediatr Radiol. 2021 Nov;51(12):2117-2127. doi: 10.1007/s00247-021-05080-1. Epub 2021 Jun 12. Pediatr Radiol. 2021. PMID: 34117892 Free PMC article. Review.
-
Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future design.Chang Gung Med J. 2012 Mar-Apr;35(2):125-39. doi: 10.4103/2319-4170.106159. Chang Gung Med J. 2012. PMID: 22537927 Review.
Cited by
-
Comprehensive assessment of blood-brain barrier opening and sterile inflammatory response: unraveling the therapeutic window.Sci Rep. 2024 Jul 24;14(1):17036. doi: 10.1038/s41598-024-67916-8. Sci Rep. 2024. PMID: 39043894 Free PMC article.
-
Laboratory-Scale Production of Sterile Targeted Microbubbles.Methods Mol Biol. 2022;2394:591-599. doi: 10.1007/978-1-0716-1811-0_31. Methods Mol Biol. 2022. PMID: 35094348 Free PMC article.
-
Identifying new therapeutics for focused ultrasound-enhanced drug delivery in the management of glioblastoma.Front Oncol. 2025 Mar 13;15:1507940. doi: 10.3389/fonc.2025.1507940. eCollection 2025. Front Oncol. 2025. PMID: 40182047 Free PMC article. Review.
-
Formulation and Characterization of Chemically Cross-linked Microbubble Clusters.Langmuir. 2019 Aug 20;35(33):10977-10986. doi: 10.1021/acs.langmuir.9b00475. Epub 2019 Aug 7. Langmuir. 2019. PMID: 31310715 Free PMC article.
-
Effect of Acoustic Parameters and Microbubble Concentration on the Likelihood of Encapsulated Microbubble Coalescence.Ultrasound Med Biol. 2021 Oct;47(10):2980-2989. doi: 10.1016/j.ultrasmedbio.2021.06.020. Epub 2021 Jul 31. Ultrasound Med Biol. 2021. PMID: 34344561 Free PMC article.
References
-
- Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968;3:356–66. - PubMed
-
- Keller MW, Glasheen W, Kaul S. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 1989;2:48–52. - PubMed
-
- Jablonski EG, Dittrich HC, Bartlett JM, Podell SB. Ultrasound Contrast Agents: The Advantage of Albumin Microsphere Technology In: Thompson DO, Chimenti DE, editors. Rev. Prog. Quant. Nondestruct. Eval, Springer; US; 1998, p. 15–22. doi:10.1007/978-1-4615-5339-7_2. - DOI
-
- Unger E, Shen DK, Fritz T, Lund P, Wu GL, Kulik B, et al. Gas-filled liposomes as echocardiographic contrast agents in rabbits with myocardial infarcts. Invest Radiol 1993;28:1155–9. - PubMed
-
- Schneider M Characteristics of SonoVue(TM). Echocardiogr Mt Kisco N 1999;16:743–6. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources